EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY-NC 4.0

Correction to: Factors associated with treatment discontinuation and age-stratified safety of abatacept in Japanese patients with rheumatoid arthritis: 5-year results of the ORIGAMI study

Modern Rheumatology · 04.11.2026 · 36 (6) · 1067-1067

DOI: 10.1093/mr/roag081 ↗

Kurz gefasst

Korrektur in der Zeitschrift Modern Rheumatology, online erschienen am 12.09.2026. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to: Factors associated with treatment discontinuation and age-stratified safety of abatacept in Japanese patients with rheumatoid arthritis: 5-year results of the ORIGAMI study. Modern Rheumatology, 36(6), 1067-1067. https://doi.org/10.1093/mr/roag081

Vancouver

Correction to: Factors associated with treatment discontinuation and age-stratified safety of abatacept in Japanese patients with rheumatoid arthritis: 5-year results of the ORIGAMI study. Modern Rheumatology. 2026;36(6):1067-1067. doi:10.1093/mr/roag081

BibTeX
@article{euvimed2026,
  title = {Correction to: Factors associated with treatment discontinuation and age-stratified safety of abatacept in Japanese patients with rheumatoid arthritis: 5-year results of the ORIGAMI study},
  journal = {Modern Rheumatology},
  year = {2026},
  volume = {36},
  number = {6},
  pages = {1067--1067},
  doi = {10.1093/mr/roag081}
}
Kostenlos starten →